| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 08/05/2010 | US20100196475 Controlled release tablet formulation containing magnesium aluminometasilicate |
| 08/05/2010 | US20100196472 Modified release compositions of milnacipran |
| 08/05/2010 | US20100196459 Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms |
| 08/05/2010 | US20100196455 Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof |
| 08/05/2010 | US20100196443 Use of cordyceps species or extract thereof in the egg production |
| 08/05/2010 | US20100196399 LDL Receptor-Related Proteins 1 and 2 and Treatment of Bone or Cartilage Conditions |
| 08/05/2010 | US20100196376 Method for reducing allergen-induced airway hyperresponsiveness |
| 08/05/2010 | US20100196344 Compositions and methods for treating pancreatic insufficiency |
| 08/05/2010 | US20100196285 Use of Deuterium Oxide to Treat Virus-Based Diseases of the Respiratory Tract |
| 08/05/2010 | CA2751239A1 Azetidines as histamine h3 receptor antagonists |
| 08/05/2010 | CA2751054A1 Dimeric pyrrolopyrimidinedione and its use in therapy of respiratory diseases |
| 08/05/2010 | CA2750796A1 5-ht4 inhibitors for treating airway diseases, in particular asthma |
| 08/05/2010 | CA2750696A1 Use of a synergistic combination of hypothiocyanite and/or hypohalite ions and lactoferrin for preparing a treatment for cystic fibrosis |
| 08/05/2010 | CA2750452A1 N-acyl anthranilic acid derivative or salt thereof |
| 08/05/2010 | CA2750188A1 Low-molecular polysulfated hyaluronic acid derivative and medicine containing same |
| 08/04/2010 | EP2213743A1 Albumin fusion proteins |
| 08/04/2010 | EP2212323A2 Imidazo [1,2-a] pyridine derivatives useful as alk inhibitors |
| 08/04/2010 | EP2212312A2 5-lipoxygenase activating protein (flap) inhibitor |
| 08/04/2010 | EP2212276A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor |
| 08/04/2010 | EP2211865A2 Combination comprising purine derivatives and other compounds and the use thereof for the treatment of inflammatory and obstructive airway diseases |
| 08/04/2010 | EP2211863A1 Combination therapy |
| 08/04/2010 | EP2211841A1 A method of prophylaxis and agents for use therein |
| 08/04/2010 | EP1999128B1 Tetomilast polymorphs |
| 08/04/2010 | EP1343769B1 Benzoylpyridazines |
| 08/04/2010 | CN1943637B Medicine for eliminating sputum and relieving asthma and its preparing method |
| 08/04/2010 | CN1906302B Genetically modified plants comprising SARS-CoV viral nucleotide sequences and methods of use thereof for immunization against SARS |
| 08/04/2010 | CN101796042A Novel compounds 951: a biphenyloxypropanoic acid as CRTH2 modulator and intermediates |
| 08/04/2010 | CN101796039A Phenylacetic acid compound |
| 08/04/2010 | CN101796028A Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 08/04/2010 | CN101795693A Methods of treating or preventing respiratory tract infection comprising administering cholecalciferol |
| 08/04/2010 | CN101792417A Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases |
| 08/04/2010 | CN101791382A Chinese herbal medicine combination for treating nasal bleeding |
| 08/04/2010 | CN101791373A Compound combined medicine for treating upper respiratory tract infection of poultry and preparation method thereof |
| 08/04/2010 | CN101791372A Chinese medicine for treating radiation pharyngitis |
| 08/04/2010 | CN101791366A Method for testing quality of Discorea nipponica Makino in different places and medicinal materials of same genera |
| 08/04/2010 | CN101791353A Sustained-release matrix type compound Chuanping sustained-release tablet and preparation method and application thereof |
| 08/04/2010 | CN101791338A Medicament for resisting influenza and preparation method and application thereof |
| 08/04/2010 | CN101791325A Preparation method of Chinese goosebeery capsule for preventing and treating lung cancer |
| 08/04/2010 | CN101791313A Application of calcium disodium edentate and corticosteroid compound preparation in preparing medicine capable of inhibiting connective tissue growth factors and monoamine oxidase |
| 08/04/2010 | CN101791303A Calcium disodium edentate oral preparation and application thereof in medicine capable of inhibiting connective tissue growth factors and monoamine oxidase |
| 08/04/2010 | CN101791302A Medicinal composition containing sodium ferulate and preparation method thereof |
| 08/04/2010 | CN101791292A Application of polygonin atomizing agent as asthma-treating medicine |
| 08/04/2010 | CN101647849B Nose drop for curing rhinitis and preparation method thereof |
| 08/04/2010 | CN101380328B Medicine for treating coryza and its preparation method |
| 08/04/2010 | CN101112612B Method for making coated tablets for relieving cough and asthma |
| 08/04/2010 | CN101081296B Method for preparing b type haemophilus influenzae capsular polysaccharide and united vaccines thereof |
| 08/03/2010 | US7767685 8-pyrazolo-xanthine derivatives such as 2-[3-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-5-methyl-pyrazol-1-yl]-N-phenyl-acetamide, used for treating asthma, rhinitis, dermatitis, diabetes, tumors, reperfusion injuries, inflammatory bowel disease, autoimmune diseases and vison defects |
| 08/03/2010 | US7767679 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 08/03/2010 | US7767207 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders |
| 08/03/2010 | US7767198 Aerosolizing dry powder of interleukin-4 receptor with carbohydrage, lipid, buffer, peptide, protein, Group II metal, or oligopeptide excipient; small aerodynamic particle size; dispersion into gas stream to make inhalant; high dispersibilities |
| 08/03/2010 | CA2526228C Quinoline derivatives as phosphodiesterase inhibitors |
| 08/03/2010 | CA2441792C Carboline derivatives as inhibitors of phosphodiesterase 5 (pdes) for the treatment of cardiovascular diseases and erectile dysfunction |
| 08/03/2010 | CA2409828C Formulation based in heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 08/03/2010 | CA2402199C Amidino compounds useful as nitric oxide synthase inhibitors |
| 08/03/2010 | CA2401342C Human antibodies against eotaxin and their use |
| 08/03/2010 | CA2359776C Methods for the prevention and treatment of diseases caused by an inflammatory response mediated by endogenous substance p by using anti-substance p antibodies |
| 07/29/2010 | WO2010085820A2 Tricyclic compounds as antagonists of prostaglandin d2 receptors |
| 07/29/2010 | WO2010084767A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity |
| 07/29/2010 | WO2010084188A1 Delayed-release glucocorticoid treatment of asthma |
| 07/29/2010 | WO2010084050A2 Quinazolinone derivatives useful as vanilloid antagonists |
| 07/29/2010 | WO2010083778A1 Lung targeting injectable pharmaceutical composition of liposome |
| 07/29/2010 | WO2010064958A3 Protein kinase c inhibitors exhibiting an anti-inflammatory, anti-allergic and anti-asthma effect |
| 07/29/2010 | WO2010056877A3 Haloalkyl containing compounds as cysteine protease inhibitors |
| 07/29/2010 | WO2010042652A3 Heteroalkyl biphenyl antagonists of prostaglandin d2 receptors |
| 07/29/2010 | WO2010039502A3 Micrornas in idiopathic pulmonary fibrosis |
| 07/29/2010 | US20100190838 Connective Tissue Growth Factor Fragments and Methods and Uses Thereof |
| 07/29/2010 | US20100190830 (3-Amino-1,2,3,4-Tetrahydro-9H-Carbazol-9-yl)-Acetic Acid Derivatives |
| 07/29/2010 | US20100190817 Large substituent, non-phenolic amine opioids |
| 07/29/2010 | US20100190788 Amide derivatives as kinase inhitors |
| 07/29/2010 | US20100190784 Organic Compounds |
| 07/29/2010 | US20100190773 Anti-Cytokine Heterocyclic Compounds |
| 07/29/2010 | US20100190767 Compounds for the treatment of inflammatory diseases |
| 07/29/2010 | US20100190761 Diphenyl substituted alkanes |
| 07/29/2010 | US20100190759 Nk 1 antagonists |
| 07/29/2010 | US20100190756 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS |
| 07/29/2010 | US20100190722 Substance p and thyrotropin releasing hormone for therapeutic applications |
| 07/29/2010 | US20100190717 Use of melanin concentrating hormone and met-enkephalin as therapeutic agents |
| 07/29/2010 | US20100190716 Use of a platelet fibrinogen receptor hexapeptide antagonist and alpha-endorphin as therapeutic agents |
| 07/29/2010 | US20100190714 RNAi Inhibition of Alpha-ENaC Expression |
| 07/29/2010 | US20100190713 Use of the peptide thymosin beta 4 alone or in combination with cecropin a as a therapeutic agent |
| 07/29/2010 | US20100190712 Use of peptide yy, alone or in combination with glucagon-like peptide, for use in medicine |
| 07/29/2010 | US20100190711 Big gastrin i as a therapeutic agent |
| 07/29/2010 | US20100189808 Sputum dissolving suctioning solution for endotracheal and tracheostomy tubes |
| 07/29/2010 | US20100189785 Use of D-ribose for fatigued subjects |
| 07/29/2010 | US20100189780 Novel Powderous Medicaments Comprising Tiotropium and Salmeterol and Lactose as Carrier |
| 07/29/2010 | US20100189686 Albumin Fusion Proteins |
| 07/29/2010 | CA2749646A1 Delayed-release glucocorticoid treatment of asthma |
| 07/29/2010 | CA2747801A1 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity |
| 07/28/2010 | EP2210880A1 Benzoxazinone derivative |
| 07/28/2010 | EP2210614A1 Combinations comprising antimuscarinic agents and PDE4 inhibitors |
| 07/28/2010 | EP2210613A1 Combinations comprising antimuscarinic agents and PDE4 inhibitors |
| 07/28/2010 | EP2210603A1 Pharmaceutical composition for inhibiting the accumulation of amyloid- b protein |
| 07/28/2010 | EP2210602A1 Compositions for the treatment of symptoms associated with respiratory inflammations |
| 07/28/2010 | EP2209771A1 Cyclobutyl carboxylic acid derivatives |
| 07/28/2010 | EP2209769A1 Novel crystalline salts of montelukast |
| 07/28/2010 | EP1954677B1 Thiomorpholine compound and process for preparing the same |
| 07/28/2010 | EP1458392B9 Acridones as inhibitors of impdh enzyme |
| 07/28/2010 | CN1905875B The use of quaternary pyridinium salts as vasoprotective agents |
| 07/28/2010 | CN1794988B Composition for treating vascular hyperpermeable disease |
| 07/28/2010 | CN101790517A Inhibitor of binding of s1p1 |